IIM
IDXX icon

IFC & Insurance Marketing’s Idexx Laboratories IDXX Stock Holding History

IFC & Insurance Marketing’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-16
Closed -$11K – 332
2025
Q4 		$11K Buy
+16
New +$10.9K 0.01% 376

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

IFC & Insurance Marketing's IDXX Position: Q1 2026 in Review

IFC & Insurance Marketing sold out of Idexx Laboratories (IDXX) in Q1 2026, closing a stake of 16 shares — an estimated $11K sold.

IFC & Insurance Marketing first reported a position in IDXX in Q4 2025 and held it in 1 quarter. The position peaked at $11K in Q4 2025. 1,318 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • IFC & Insurance Marketing reported no remaining Idexx Laboratories position as of Q1 2026 after selling out during the quarter.
  • IFC & Insurance Marketing sold 16 Idexx Laboratories shares in Q1 2026, an estimated $11K.
  • IFC & Insurance Marketing first reported a position in Idexx Laboratories in Q4 2025 and held it in 1 quarter.
  • IFC & Insurance Marketing's Idexx Laboratories position peaked at $11K in Q4 2025.
  • 1,318 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on IFC & Insurance Marketing's 13F filing for Q1 2026, filed 17 Apr 2026.